TennCare - As introduced, requires a managed care organization or pharmacy benefits manager that is contracted with the bureau to reimburse a claim for a long-acting injectable drug intended for treatment and prevention of human immunodeficiency virus and administered in a pharmacy, physician's office, clinic, ambulatory surgical treatment center, or hospital. - Amends TCA Title 4; Title 56 and Title 71.

Summary

The bill adds a new requirement that any managed care organization or pharmacy benefits manager working with TennCare must pay for long‑acting injectable HIV treatment or prevention drugs when they are administered in a pharmacy, doctor’s office, clinic, ambulatory surgical center, or hospital. It treats these drugs as both medical and pharmacy benefits, but only allows one reimbursement per service. The change aims to improve access to these HIV medications for TennCare enrollees.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share